Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Cardio-oncology/onco-cardiology Hong RA; Iimura T; Sumida KN; Eager RMClin Cardiol 2010[Dec]; 33 (12): 733-7An understanding of onco-cardiology or cardio-oncology is critical for the effective care of cancer patients. Virtually all antineoplastic agents are associated with cardiotoxicity, which can be divided into 5 categories: direct cytotoxic effects of chemotherapy and associated cardiac systolic dysfunction, cardiac ischemia, arrhythmias, pericarditis, and chemotherapy-induced repolarization abnormalities. Radiation therapy can also lead to coronary artery disease and fibrotic changes to the valves, pericardium, and myocardium. All patients being considered for chemotherapy, especially those who have prior cardiac history, should undergo detailed cardiovascular evaluation to optimize the treatment. Serial assessment of left ventricular systolic function and cardiac biomarkers might also be considered in selected patient populations. Cardiotoxic effects of chemotherapy might be decreased by the concurrent use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or beta-blockers. Antiplatelet or anticoagulation therapy might be considered in patients with a potential hypercoagulable state associated with chemotherapy or cancer. Open dialogue between both cardiologists and oncologists will be required for optimal patient care.|*Cardiology[MESH]|*Medical Oncology[MESH]|*Patient Care Team[MESH]|Anticoagulants/therapeutic use[MESH]|Antineoplastic Agents/*adverse effects[MESH]|Cardiovascular Agents/therapeutic use[MESH]|Cooperative Behavior[MESH]|Heart Diseases/chemically induced/diagnosis/*etiology/prevention & control[MESH]|Heart Function Tests[MESH]|Humans[MESH]|Predictive Value of Tests[MESH]|Radiation Injuries/diagnosis/*etiology/prevention & control[MESH]|Thrombophilia/*chemically induced/diagnosis/prevention & control[MESH] |